Keenova Therapeutics plc, a leading global developer and manufacturer of branded therapeutics, announced today that it will report its fourth-quarter 2025 financial results on Tuesday, March 31, 2026, ...
Government advisors have called for more support in tackling ketamine-related harms, and a national alert on its public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results